Skip to main content

Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates

πŸ“„ Original study β†—
Barrett, Frederick S, Griffiths, Roland R β€’ 2018 Current Era β€’ methodology

Plain English Summary

This review digs into what happens in the brain when psilocybin (the active ingredient in magic mushrooms) triggers full-blown mystical experiences β€” and the numbers are striking. Under carefully controlled lab conditions, a single dose produced complete mystical experiences in roughly 60% of volunteers, with effects still felt over a year later. Researchers developed a validated questionnaire capturing four dimensions: mystical unity, positive mood, time and space dissolving, and the feeling that words just can't capture what happened. Here's where it gets really compelling: the strength of the mystical experience actually predicted how well psilocybin worked as therapy for addiction and cancer-related distress. The brain mechanism? The default mode network β€” a set of brain regions active during self-referential thinking β€” gets disrupted, much like what happens during deep meditation. This links psychedelic science to broader consciousness research, including phenomena like near-death experiences.

Research Notes

Key synthesis paper linking psychedelic neuroscience to consciousness studies. Directly extends Carhart-Harris et al. (2012) and Brewer et al. (2011) DMN findings. Relevant to the library as background on altered states of consciousness that overlap phenomenologically with reported psi experiences and NDEs.

Reviews the phenomenology, measurement, and neural correlates of mystical experiences occasioned by classic hallucinogens. Under double-blind conditions, psilocybin (30 mg/70 kg) produced complete mystical experiences in 57-67% of participants, with effects persisting at 14-month follow-up. The psychometrically validated 30-item Mystical Experience Questionnaire (MEQ30) captures four factors: Mystical, Positive Mood, Transcendence of Time and Space, and Ineffability. Mystical experience scores mediated therapeutic outcomes in addiction and cancer-related distress. Proposes a functional neural model in which disruption of the default mode network β€” particularly decreased activity in the medial prefrontal cortex, posterior cingulate cortex, and angular gyrus β€” underlies the unity and timelessness central to mystical experience, drawing parallels with meditation neuroimaging.

Links

Related Papers

More in Methodology

πŸ“‹ Cite this paper
APA
Barrett, Frederick S, Griffiths, Roland R (2018). Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Current Topics in Behavioral Neurosciences. https://doi.org/10.1007/7854_2017_474
BibTeX
@article{barrett_griffiths_2018_hallucinogens_mystical,
  title = {Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates},
  author = {Barrett, Frederick S and Griffiths, Roland R},
  year = {2018},
  journal = {Current Topics in Behavioral Neurosciences},
  doi = {10.1007/7854_2017_474},
}